Study Finds Common Vitamin D2 Supplements May Reduce Natural Vitamin D3 Levels

A recent scientific investigation has raised concerns about the widespread use of vitamin D2 supplements, suggesting that the compound can inadvertently suppress the body’s own vitamin D3 levels, the form primarily generated through sunlight exposure.

The research, conducted by a team of nutrition and endocrinology experts, compared the biochemical effects of the two main supplemental forms of the nutrient. While both vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) are used to address deficiencies, the study found that regular intake of vitamin D2 was associated with a measurable decline in circulating vitamin D3 concentrations in participants.

Vitamin D3 is generally considered the more potent and bioavailable version of the vitamin, playing a crucial role in calcium metabolism, bone health, and immune function. It is produced in the skin when ultraviolet B (UV‑B) rays convert a cholesterol precursor into the active hormone. In contrast, vitamin D2 originates from plant sources and is often used in fortified foods and over‑the‑counter tablets.

The investigators highlighted that not all vitamin D supplements are chemically identical, and the differing molecular structures can influence how the body processes each form. Their findings suggest that supplementing with vitamin D2 may compete with or accelerate the breakdown of vitamin D3, potentially undermining the intended benefit of correcting a deficiency.

Health professionals are urged to consider these results when recommending supplementation, especially for individuals who rely heavily on pills rather than sunlight or dietary intake. The study does not call for an outright ban on vitamin D2 products, but it does recommend that clinicians evaluate a patient’s overall vitamin D status and possibly favor vitamin D3 formulations when appropriate.

Experts note that the implications extend beyond individual choices; manufacturers, regulators, and public‑health agencies may need to reassess labeling standards and consumer guidance. Further research is planned to determine the long‑term clinical outcomes of reduced vitamin D3 levels linked to vitamin D2 use, as well as to explore whether dosage adjustments can mitigate the effect.

In the meantime, consumers are advised to consult healthcare providers before initiating or changing vitamin D supplementation, and to maintain balanced exposure to natural sunlight when feasible, as a complementary strategy for supporting optimal vitamin D status.